Literature DB >> 27811478

Deletion of Irf3 and Irf7 Genes in Mice Results in Altered Interferon Pathway Activation and Granulocyte-Dominated Inflammatory Responses to Influenza A Infection.

Bastian Hatesuer1, Hang Thi Thu Hoang, Peggy Riese, Stephanie Trittel, Ingo Gerhauser, Husni Elbahesh, Robert Geffers, Esther Wilk, Klaus Schughart.   

Abstract

The interferon (IFN) pathway plays an essential role in the innate immune response following viral infections and subsequent shaping of adaptive immunity. Infections with influenza A viruses (IAV) activate the IFN pathway after the recognition of pathogen-specific molecular patterns by respective pattern recognition receptors. The IFN regulatory factors IRF3 and IRF7 are key players in the regulation of type I and III IFN genes. In this study, we analyzed the role of IRF3 and IRF7 for the host response to IAV infections in Irf3-/-, Irf7-/-, and Irf3-/-Irf7-/- knockout mice. While the absence of IRF3 had only a moderate impact on IFN expression, deletion of IRF7 completely abolished IFNα production after infection. In contrast, lack of both IRF3 and IRF7 resulted in the absence of both IFNα and IFNβ after IAV infection. In addition, IAV infection of double knockout mice resulted in a strong increase of mortality associated with a massive influx of granulocytes in the lung and reduced activation of the adaptive immune response.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27811478      PMCID: PMC6738875          DOI: 10.1159/000450705

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  26 in total

Review 1.  Inflammation and Pneumonia: Why Are Some More Susceptible than Others?

Authors:  Joseph P Mizgerd
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

2.  Defective interferon priming and impaired antiviral responses in a patient with an IRF7 variant and severe influenza.

Authors:  Michelle M Thomsen; Sofie E Jørgensen; Hans Henrik Gad; Merete Storgaard; Jakob Gjedsted; Mette Christiansen; Rune Hartmann; Trine H Mogensen
Journal:  Med Microbiol Immunol       Date:  2019-06-06       Impact factor: 3.402

3.  Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic Neurodegeneration.

Authors:  James P Barrett; Rebecca J Henry; Kari Ann Shirey; Sarah J Doran; Oleg D Makarevich; Rodney M Ritzel; Victoria A Meadows; Stefanie N Vogel; Alan I Faden; Bogdan A Stoica; David J Loane
Journal:  J Neurosci       Date:  2020-02-06       Impact factor: 6.167

4.  Attenuation of interferon regulatory factor 7 activity in local infectious sites of trachea and lung for preventing the development of acute lung injury caused by influenza A virus.

Authors:  Lei Yang; Liqun Tu; Peiyan Zhao; Ying Wang; Shengnan Wang; Wenting Lu; Yangyang Wang; Xin Li; Yongli Yu; Shucheng Hua; Liying Wang
Journal:  Immunology       Date:  2019-02-27       Impact factor: 7.397

5.  Cutaneous transcriptome analysis in NIH hairless mice.

Authors:  Zhong-Hao Ji; Jian Chen; Wei Gao; Jin-Yu Zhang; Fu-Shi Quan; Jin-Ping Hu; Bao Yuan; Wen-Zhi Ren
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

6.  Baicalin Downregulates RLRs Signaling Pathway to Control Influenza A Virus Infection and Improve the Prognosis.

Authors:  Peng Pang; Ke Zheng; Sizhi Wu; Huachong Xu; Li Deng; Yucong Shi; Xiaoyin Chen
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-26       Impact factor: 2.629

7.  miR-144 attenuates the host response to influenza virus by targeting the TRAF6-IRF7 signaling axis.

Authors:  Carrie M Rosenberger; Rebecca L Podyminogin; Alan H Diercks; Piper M Treuting; Jacques J Peschon; David Rodriguez; Madhumati Gundapuneni; Mitchell J Weiss; Alan Aderem
Journal:  PLoS Pathog       Date:  2017-04-05       Impact factor: 6.823

8.  Of mice and men: the host response to influenza virus infection.

Authors:  Heike Kollmus; Carolin Pilzner; Sarah R Leist; Mark Heise; Robert Geffers; Klaus Schughart
Journal:  Mamm Genome       Date:  2018-06-15       Impact factor: 2.957

9.  Cellular nucleic acid-binding protein is essential for type I interferon-mediated immunity to RNA virus infection.

Authors:  Yongzhi Chen; Xuqiu Lei; Zhaozhao Jiang; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

10.  Treatment with the NR4A1 agonist cytosporone B controls influenza virus infection and improves pulmonary function in infected mice.

Authors:  Benoit Egarnes; Marie-Renée Blanchet; Jean Gosselin
Journal:  PLoS One       Date:  2017-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.